CATIE Study Still Shapes Psychiatry Training but Rarely Guides State Policy

The Clinical Antipsychotic Trials of Intervention Effectiveness, or CATIE, occupies an increasingly split position in American psychiatry: it remains a fixture of residency classrooms, yet it has largely disappeared from the policy documents that govern state-level psychiatric care. That is the central finding of a cross-sectional mixed-methods survey published in Community Mental Health Journal, which asked U.S. psychiatry residency program directors and state mental health program medical directors how, and whether, the CATIE study still informs their work.

The survey, conducted by Leon Ravin, Cole Edwards, and Alexander Lin, was distributed to psychiatry residency program directors across the United States and to members of the Medical Directors Council of the National Association of State Mental Health Program Directors. Participation was voluntary and anonymous, and the authors obtained institutional review board exemption. The instrument combined closed-ended questions with open-ended prompts, allowing the researchers to quantify teaching and policy practices while also capturing narrative explanations. Quantitative responses were summarized descriptively, and qualitative answers were analyzed thematically and categorized by sentiment. In total, 75 responses were analyzed: 60 from residency program directors and 15 from state medical directors.

The educational picture that emerged was one of durable relevance. Among residency directors, 56 percent reported teaching the CATIE study for its clinical significance, while 32 percent included it for its historical relevance; only 12 percent said they did not routinely cover it in training. In other words, nearly nine in ten programs still expose trainees to the trial in some form. The open-ended responses explained why. Directors described CATIE as a valuable vehicle for teaching study design, clinical decision-making, and the evolution of antipsychotic therapy, positioning it less as a prescribing guide and more as a case study in how large pragmatic trials are constructed, interpreted, and translated, or not translated, into practice.

The policy picture was starkly different. Eighty percent of state medical directors reported that CATIE findings no longer inform treatment protocols or formulary decisions at their agencies. This contrast between the classroom and the statehouse is the survey’s most consequential observation. The authors characterize it as a widening gap between academic instruction and policy application of psychiatric evidence, a divergence in which the same body of research is treated as pedagogically valuable by educators while carrying little operational weight for administrators responsible for real-world treatment systems.

The qualitative responses added nuance to that divide. Respondents acknowledged CATIE’s continued educational value but also raised concerns regarding the generalizability of its findings, a limitation that helps explain why the trial’s influence on contemporary protocols has faded. The survey’s authors argue that the divergence they documented points to a need for updated research that reflects contemporary clinical realities and pharmacologic advancements rather than relying on a trial from an earlier era of antipsychotic therapy.

Methodologically, the study is a snapshot rather than a longitudinal analysis. Its cross-sectional design captures attitudes at a single point in time, and its sample, while spanning two influential leadership groups, comprised 75 voluntary respondents whose views may not represent all residency programs or all state mental health authorities. The mixed-methods approach strengthens interpretation by pairing percentages with thematic narrative, but the authors present the findings as descriptive of the surveyed groups rather than as nationally representative estimates. The sentiment categorization of open-ended answers further contextualizes the numbers, showing that even where CATIE is taught, it is often framed as historically important rather than as directly guiding current prescribing.

What the survey ultimately documents is a study in transition. CATIE retains enough conceptual weight that the overwhelming majority of residency programs still teach it, valued for its clinical significance and its usefulness in teaching study design and clinical decision-making. At the same time, the institutions that translate evidence into formularies and protocols have largely moved on. The authors suggest that this asymmetry between academic and institutional priorities is itself a finding worth acting on: if landmark trials are to retain policy relevance, the evidence base must be periodically renewed so that what is taught in training and what is applied in state systems do not continue to drift apart.

Subject of Research: A mixed-methods survey of U.S. psychiatry residency and state medical directors on the continuing educational and policy influence of the CATIE schizophrenia trial

Article Title: The Legacy Impact of the CATIE Study on Healthcare Policy and Psychiatric Resident Education: A Cross-Sectional Mixed-Methods Survey of U.S. Psychiatry Residency and State Medical Directors

Article References: Ravin, L., Edwards, C., & Lin, A. (2026). The Legacy Impact of the CATIE Study on Healthcare Policy and Psychiatric Resident Education: A Cross-Sectional Mixed-Methods Survey of U.S. Psychiatry Residency and State Medical Directors. Community Mental Health Journal. https://doi.org/10.1007/s10597-026-01742-2

Image Credits: AI Generated

DOI: 10.1007/s10597-026-01742-2

Keywords: CATIE, schizophrenia, antipsychotics, psychiatry residency, medical education, health policy, state mental health, survey research, mixed methods, Community Mental Health Journal, Legacy, Impact